0001104659-14-044028.txt : 20140623 0001104659-14-044028.hdr.sgml : 20140623 20140604171600 ACCESSION NUMBER: 0001104659-14-044028 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20140602 FILED AS OF DATE: 20140604 DATE AS OF CHANGE: 20140604 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ophthotech Corp. CENTRAL INDEX KEY: 0001410939 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE PENN PLAZA STREET 2: 19TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10119 BUSINESS PHONE: 212-845-8200 MAIL ADDRESS: STREET 1: ONE PENN PLAZA STREET 2: 19TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10119 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PEACOCK BRUCE CENTRAL INDEX KEY: 0001228459 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36080 FILM NUMBER: 14891736 4 1 a4.xml 4 X0306 4 2014-06-02 0 0001410939 Ophthotech Corp. OPHT 0001228459 PEACOCK BRUCE C/O OPHTHOTECH CORPORATION ONE PENN PLAZA, 19TH FLOOR NEW YORK NY 10119 0 1 0 0 CFO & CBO Common Stock 2014-06-02 4 M 0 8837 1.6520 A 8837 D Common Stock 2014-06-02 4 S 0 8137 39.88 D 700 D Common Stock 2014-06-02 4 S 0 700 40.80 D 0 D Common Stock 2014-06-03 4 M 0 5094 1.6520 A 5094 D Common Stock 2014-06-03 4 S 0 5094 40.41 D 0 D Stock Option (Right To Buy) 1.6520 2014-06-02 4 D 0 8837 0.00 D 2020-09-27 Common Stock 8837 47049 D Stock Option (Right To Buy) 1.6520 2014-06-03 4 D 0 5094 0.00 D 2020-09-27 Common Stock 5094 41955 D The exercise of options and sales of common stock reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2013. These shares were disposed of in multiple transactions on June 2, 2014 at actual sales prices ranging from $39.625 to $40.45 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by the staff of the Securities Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. These shares were disposed of in multiple transactions on June 2, 2014 at actual sales prices ranging from $40.67 to $40.885 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by staff of the Securities Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. These shares were disposed of in multiple transactions on June 3, 2014 at actual sales prices ranging from $40.25 to $40.93 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by staff of the Securities Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. This option was granted on September 28, 2010 and is currently exercisable for all shares underlying the option. Exhibit Index 24.1 - Power of Attorney /s/ Tom Biancardi, as Attorney-in-Fact for Bruce Peacock 2014-06-04 EX-24.1 2 ex-24d1.htm EX-24.1

Exhibit 24.1

 

POWER OF ATTORNEY

 

Know all by these presents that the undersigned hereby constitutes and appoints each of Justin Vogel and Barbara Wood, or either of them signing singly, and with full power of substitution, the undersigned’s true and lawful attorney-in-fact to:

 

(1)                                 prepare, execute in the undersigned’s name and on the undersigned’s behalf, and submit to the U.S. Securities and Exchange Commission (the “SEC”) a Form ID, including amendments thereto, and any other documents necessary or appropriate to obtain codes and passwords enabling the undersigned to make electronic filings with the SEC of reports required by Section 16(a) of the Securities Exchange Act of 1934, as amended, or any rule or regulation of the SEC;

 

(2)                                 execute for and on behalf of the undersigned, in the undersigned’s capacity as an officer and/or director of Ophthotech Corporation (the “Company”), Forms 3, 4, and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended, and the rules thereunder;

 

(3)                                 do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4, or 5, complete and execute any amendment or amendments thereto, and timely file such form with the SEC and any stock exchange or similar authority; and

 

(4)                                 take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact’s discretion.

 

The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact’s substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted.  The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned’s responsibilities to comply with Section 16 of the Securities Exchange Act of 1934, as amended.

 

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned’s holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.

 

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 4th day of June, 2014.

 

 

 

/s/ Bruce Peacock

 

Signature

 

 

 

Bruce Peacock